首页 >
法规速递
-
Document: Annex to agenda of the CHMP meeting 18-21 May 2026-2026/5/18
2026-05-19查看详情 > -
国家药监局关于恢复销售使用印度瑞迪博士实验室有限公司富马酸喹硫平的公告（2023年第79号）-2023/6/20
2023-06-21查看详情 > -
Draft Guidance: Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act - Revision 2-2023/12/6
2023-12-21查看详情 > -
Document: CHMP and Rapporteurs' assessment report template on Similarity Rev. 03.23-2025/1/22
2025-01-23查看详情 > -
Page: EU Innovation Network (EU-IN)-2025/2/24
2025-02-25查看详情 > -
Document: Reflection paper on a tailored clinical approach in biosimilar development-2025/4/1
2025-04-02查看详情 > -
图解海报 |《化妆品安全风险监测与评价管理办法》系列解读（一）-2025/5/13
2025-05-14查看详情 > -
Document: New product information wording: extracts from PRAC recommendations on signals adopted at the 7-10 April 2025 PRAC-2025/6/19
2025-06-20查看详情 > -
Page: Good pharmacovigilance practices (GVP)-2025/7/24
2025-07-25查看详情 > -
Document: Agenda - PDCO agenda of the 9-12 September 2025 meeting-2025/9/9
2025-09-10查看详情 >
